跳至主要内容
临床试验/NCT04180267
NCT04180267终止不适用

Efficacy of Low-magnitude High-frequency Vibration (LMHFV) on Musculoskeletal Health of Subjects on Wheelchair, a Randomized Controlled Study.

Chinese University of Hong Kong3 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2019年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
37
试验地点
3
主要终点
Vertebral BMD

研究概览

简要总结

Osteoporosis is an age-related disease with progressive loss of bone, leading to fragile bone. It is one of the major health issues in elderly and causes medical, social and economic impacts globally. Patients with osteoporosis have high risk of osteoporotic fractures. Low-magnitude high-frequency vibration (LMHFV) is a non-invasive biophysical intervention providing whole-body mechanical stimulation. Previous studies showed that LMHFV is beneficial to muscle strength(1), postural control(2), balancing ability(3, 4), new bone formation(5-7), spinal bone mineral density (BMD)(8), and blood circulation(9). During the LMHFV treatment, elderly needs to stand upright on the platform for 20min/day. However, some elderlies with poor standing ability cannot stand for a long period. Therefore, the design of vibration platform is modified for the disabled patients and the efficacy of LMHFV on this group of elderlies will be verified. It is hypothesized that new design of LMHFV is beneficial to wheelchair users in terms of vertebral bone mineral density, muscle health and musculoskeletal functions.

详细描述

This study is a single-blinded randomized controlled trial to investigate the effect of LMHFV on vertebral BMD, muscle health, balancing ability and functional ability in wheelchair users (mainly on wheelchair for outdoor activities).

Healthy elderlies aged 65 years or above, with walking difficulties and using wheelchair are eligible. We exclude anyone who: [1] cannot stand and walk independently, [2] have vibration treatment before, [3] with malignancy, [4] with acute fractures or severe osteoarthritis (18), [5] with cardiovascular concern such as with pace-maker in-situ, [6] with chronic inflammatory conditions known to affect muscle metabolism such as rheumatoid arthritis, and [7] with high frequency of physical activities, such as subjects who participated in regular exercise five times a week or more.

Recruited subjects will be randomized to either LMHFV or control group. Subject assigned to LMHFV group will receive LMHFV (35Hz, 0.3g, 20min/day, at least 3 times/week) for 6 months. The primary outcome is BMD at the lumbar spine to be assessed by dual-energy X-ray absorptiometry (DXA) that is clinically recommended for the diagnosis of osteoporosis. All primary and secondary outcome assessments for all groups will be performed in the investigators' institute at baseline and 6 months post-treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects of both genders aged ≥ 65 years
  • Wheelchair users with walking difficulties
  • Subjects with good general health conditions

排除标准

  • Subjects cannot stand and walk independently
  • Subjects who had vibration treatment before
  • Subjects with malignancy
  • Subjects with acute fractures or severe osteoarthritis
  • Subjects with cardiovascular concern such as with pace-maker in-situ
  • Subjects with chronic inflammatory conditions known to affect muscle metabolism such as rheumatoid arthritis
  • Subjects with high frequency of physical activities, such as subjects who participated in regular exercise five times a week or more

结局指标

主要结局

Vertebral BMD

时间窗: Half year

BMD will be assessed by standard DXA equipment (Delphi W, Hologic, Waltham, MA, USA) which is a gold standard assessment for osteoporosis recommended by World Health Organization (WHO). Spine and hip are the two sites used for the diagnosis of osteoporosis and will be both performed.

次要结局

  • Biodex Balance System(Half year)
  • 36-item Short-Form Health Survey (SF-36)(Half year)
  • Modified functional reach test(Half year)
  • Muscle strength assessment(Half year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor CHEUNG Wing hoi, Louis

Associate Professor of Orthopaedics and Traumatology

Chinese University of Hong Kong

研究点 (3)

Loading locations...

相似试验